In the wake of raising more than $51 million in backing, a growing startup biosciences company says it wants to build new research facilities in Boulder.
The company already has an address on the east side of the city at 1880 S. Flatiron Court near the banks of the South Boulder Creek.
The two year-old Enveda Biosciences company, which has offices in San Francisco, focuses on creating new medicines derived from plants.
Using such methods as computational metabolomics, knowledge graphs, and advanced machine learning, the company is centered on discovering the next generation of small molecule therapeutics.
With employees in Europe and India, Enveda hopes to have a staff of around 50 people in Boulder, working in a 20,000-30,000 square foot facility.
Work could begin on the Boulder facility some time next spring.
In a press release, Enveda said the $51 million in backing will help the company to “advance lead molecules from plants,” which can be used for a variety of afflictions, including Parkinson’s disease.
By Garry Boulard